Delmar, NY, United States of America

Sydney Archer

This inventor holds 6 USPTO granted patents. Top assignees: Rensselaer Polytechnic Institute, Albany Medical College, World Health Organization. Active years: 1985-1999.


% Patents Active = 100.0

Average Co-Inventor Count = 1.6

ph-index = 3

Forward Citations = 47(Granted Patents)


Location History:

  • Troy, NY (US) (1985 - 1990)
  • Delmar, NY (US) (1985 - 1999)

Company Filing History:


Years Active: 1985-1999

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Sydney Archer: Innovator in Addiction Treatment

Introduction

Sydney Archer is a notable inventor based in Delmar, NY (US). She has made significant contributions to the field of addiction treatment, holding a total of 6 patents. Her work focuses on innovative methods for addressing nicotine, cocaine, and amphetamine dependencies.

Latest Patents

Among her latest patents is a method for treating nicotine addiction. This invention involves administering an effective amount of a compound with a specific formula to patients. Another significant patent addresses the treatment of cocaine and amphetamine dependency, utilizing a similar approach with a compound formula designed for effective administration.

Career Highlights

Sydney Archer has worked with esteemed institutions, including Rensselaer Polytechnic Institute. Her career is marked by a commitment to developing effective treatments for addiction, showcasing her dedication to improving public health.

Collaborations

Throughout her career, Sydney has collaborated with notable individuals such as Josef Fried and Carl Djerassi. These partnerships have contributed to her innovative research and development in addiction treatment.

Conclusion

Sydney Archer's contributions to addiction treatment through her patents highlight her role as a leading inventor in this critical field. Her work continues to impact the lives of many individuals struggling with addiction.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…